Company to appeal, insisting product is safe, after being ordered to pay $55m to woman who said she developed ovarian cancer from feminine hygiene use
Johnson & Johnson has been ordered by a US jury to pay $55m to a woman who said that using the companys talc-powder products for feminine hygiene caused her to develop ovarian cancer.
The verdict is the second straight trial loss for the company, which is facing approximately 1,200 lawsuits accusing it of not adequately warning consumers about its talc-based products cancer risks. Following a three-week trial in Missouri state court, jurors deliberated for about a day before returning a verdict in favour of the plaintiff, Gloria Ristesund.
J&J spokeswoman Carol Goodrich said the verdict contradicted 30 years of research supporting the safety of cosmetic talc. The company intended to appeal the jurys decision and would continue defending its products safety, she said.
Ristesund said she used J&Js talc-based powder products which include the well-known Baby Powder and Shower to Shower Powder on her genitals for decades. Her lawyers told how she was diagnosed with ovarian cancer and had to undergo a hysterectomy and related surgeries.